P528 Patients’ perspectives on switching from reference infliximab to CT-P13 biosimilar in patients with inflammatory bowel disease: A 12-month prospective observational cohort study
2018 ◽
Vol 12
(supplement_1)
◽
pp. S373-S374
◽
2016 ◽
Vol 10
(11)
◽
pp. 1287-1293
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S353-S353
2019 ◽
Vol 20
(9)
◽
pp. 460-466
◽
2020 ◽
Vol 44
(4)
◽
pp. 609-618